27
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Ascidians as Bioresources: An Anti-inflammatory Activity of Colonial Ascidians Eudistoma ovatum and Didemnum perlucidum

, &
Pages 254-268 | Received 03 Nov 2020, Accepted 19 Mar 2021, Published online: 02 Jun 2021
 

Abstract

Carrageenan-induced rat paw edema is a prominent inflammatory model to evaluate the anti-inflammatory effect of compounds of biological origin. In animals pretreated with Eudistoma ovatum (EO) and Didemnum perlucidum (DP) drugs, there was significant and dose-dependent inhibition of Carrageenan-induced posterior paw edema. A variety of antioxidant enzymes, such as Superoxide dismutase (SOD), Glutathione peroxidase (GPx), and Glutathione reductase (GRd) can scavenge and minimize the formation of reactive oxygen species (ROS). SOD protects cells against the damages of ROS. GPx in the presence of glutathione (GSH) accelerates the reduction of H2O2 or other organic hydroperoxides and serves as a second line of defense against hydroperoxides. The amount of platelets is affected by the increased plasma concentration of active proteins in the acute response to inflammation. Anti-inflammatory activity in carrageenan-induced paw edema in rat model was found in the extract of both ascidians E. ovatum and D. perlucidum. But the methanolic extract of E. ovatum showed more significant anti-inflammatory activity. The study includes the investigation on the effects of EO and DP on some oxidative parameters such as lipid peroxidation (LPO), SOD and GSH level, hematological parameters (RBC, WBC and Platelets, cytokines (IL 6 and TNF α), hepatic enzymes (Acid phosphatase - ACP and Alkaline phosphatase - ALP) and membrane-bound glycoproteins (hexose, hexosamine, sialic acid, and fucose). This study provided the finely tuned of the extracts in inflammatory diseases. Thus, a pharmacological basis is achieved for use of the ascidians against rheumatism and other associated diseases.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.